Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
28/06/2024 | UBS Group AG | 1305(L) | 8,795,575(L) | 456,029,530(L) 345,260,737(S) | 12.12 9.18 | |
25/06/2024 | UBS Group AG | 1306(L) | 9,149,594(L) | 463,738,233(L) 346,640,820(S) | 12.33 9.22 | |
18/06/2024 | UBS Group AG | 1306(L) | 44,958,976(L) | 467,411,858(L) 345,150,956(S) | 12.43 9.18 | |
17/06/2024 | UBS Group AG | 1305(L) | 6,194,500(L) | 480,466,755(L) 344,876,956(S) | 12.77 9.17 | |
13/06/2024 | UBS Group AG | 1306(L) | 40,415,375(L) | 465,825,640(L) 344,234,237(S) | 12.38 9.15 | |
12/06/2024 | UBS Group AG | 1205(L) | -5,681,937(L) | 484,662,403(L) 341,388,589(S) | 12.88 9.08 | |
11/06/2024 | UBS Group AG | 1104(L) | +6,194,500(L) | 492,116,122(L) 341,388,589(S) | 13.08 9.08 | |
10/06/2024 | UBS Group AG | 1205(L) | -10,654,474(L) | 485,928,622(L) 340,679,506(S) | 12.92 9.06 | |
07/06/2024 | UBS Group AG | 1104(L) | +38,151,763(L) | 496,899,369(L) 345,466,237(S) | 13.21 9.18 | |
06/06/2024 | UBS Group AG | 1306(L) | 44,421,009(L) | 466,851,680(L) 345,647,737(S) | 12.41 9.19 | |
04/06/2024 | UBS Group AG | 1306(L) | 6,194,499(L) | 477,573,094(L) 347,478,820(S) | 12.70 9.24 | |
31/05/2024 | UBS Group AG | 1305(L) | 16,341,978(L) | 476,274,107(L) 345,776,737(S) | 12.66 9.19 | |
29/05/2024 | UBS Group AG | 1306(L) | 27,375,942(L) | 464,715,344(L) 348,256,803(S) | 12.35 9.26 | |
27/05/2024 | UBS Group AG | 1305(L) | 44,032,976(L) | 456,854,958(L) 339,189,506(S) | 12.15 9.02 | |
21/05/2024 | UBS Group AG | 1306(L) | 36,144,726(L) | 468,010,118(L) 347,063,368(S) | 12.44 9.23 | |
15/05/2024 | UBS Group AG | 1305(L) | 36,704,516(L) | 459,978,822(L) 343,803,002(S) | 12.23 9.14 | |
08/05/2024 | UBS Group AG | 1305(L) | 33,428,041(L) | 459,189,005(L) 339,258,002(S) | 12.21 9.02 | |
06/05/2024 | UBS Group AG | 1306(L) | 7,635,760(L) | 452,628,915(L) 339,305,002(S) | 12.03 9.02 | |
03/05/2024 | UBS Group AG | 1305(L) | 38,178,801(L) | 455,885,777(L) 343,859,864(S) | 12.12 9.14 | |
02/05/2024 | UBS Group AG | 1101(L) | +3,569,500(L) | HKD2.939(L) | 452,878,777(L) 342,571,864(S) | 12.04 9.11 |
30/04/2024 | UBS Group AG | 1205(L) | -14,439,651(L) | 440,966,418(L) 338,692,002(S) | 11.72 9.00 | |
29/04/2024 | UBS Group AG | 1306(L) | 26,294,621(L) | 459,198,679(L) 342,571,864(S) | 12.21 9.11 | |
24/04/2024 | UBS Group AG | 1306(L) | 17,380,622(L) | 471,609,660(L) 342,571,864(S) | 12.54 9.11 | |
15/04/2024 | UBS Group AG | 1104(L) | +31,986,991(L) | 483,005,578(L) 349,908,364(S) | 12.84 9.30 | |
12/04/2024 | UBS Group AG | 1205(L) | -22,854,759(L) | 449,304,087(L) 342,003,864(S) | 11.94 9.09 | |
10/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Liu Dianbo | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Life Sciences Group Ltd | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Shorea LBG | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Ginkgo (PTC) Limited | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Pharma Holdings Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Ginkgo (PTC) Limited | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Pharma Holdings Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Life Sciences Group Ltd | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Nelumbo Investments Limited | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Nelumbo Investments Limited | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Shorea LBG | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
1 2 3 4 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 13/01/2025 18:00 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |